Birmingham University and Nonacus partnership
Industry News: Birmingham University and Nonacus partner to develop urine test for bladder cancer 02 Jul 2021 Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, and the University of Birmingham have partnered to develop a non-invasive test for bladder cancer. The test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus, and a panel of biomarkers validated by Dr. Rik Bryan and Dr. Douglas Ward from the University’s Bladder Cancer Research Centre, to diagnose the disease from urine sampl...
Source: selectscience.net